ResMed (RMD)

EBITDA Growth

12.66%

TTM · Period ending:

RMD logo

RMD EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported12.66%
RMD TTM EBITDA YoY % (85.71% → 12.66%)
High-resolution chart · PNG

RMD ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

ResMed EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
23.0677%
30.5415%
22.0597%
28.1276%
31.5886%
34.6308%
38.6078%
36.3235%
42.381%
55.8659%
67.7632%
93.4959%
94.4444%
94.5652%
100%
-5.3846%
-38.9831%
384.2105%
22.5806%
233.3333%
532.1429%
-75%
12.7273%
14.7059%
115.3846%
38.1818%
41.0256%
47.8261%
85.7143%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.